Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)

Conditions

• Chronic Kidney Disease
• Renal Insufficiency

Interventions

• DRUG: Omniscan

Sponsor

GE Healthcare

Collaborators

• [object Object]